awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54113454-F48F0B31-940F-424B-89A1-BB1835AD76C3
Q54113454-F48F0B31-940F-424B-89A1-BB1835AD76C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54113454-F48F0B31-940F-424B-89A1-BB1835AD76C3
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
P2860
Q54113454-F48F0B31-940F-424B-89A1-BB1835AD76C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54113454-F48F0B31-940F-424B-89A1-BB1835AD76C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4641a8a75fe28223cef4114bd1c741c2d7dc652
P2860
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.